Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas Journal Article


Authors: Maker, A. V.; Katabi, N.; Gonen, M.; DeMatteo, R. P.; D'Angelica, M. I.; Fong, Y.; Jarnagin, W. R.; Brennan, M. F.; Allen, P. J.
Article Title: Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas
Abstract: Introduction: There are no reliable markers of dysplasia in patients with incidentally discovered intraductal papillary mucinous neoplasms of the pancreas (IPMN). IPMN dysplasia may be associated with mucin protein (MUC) expression and histopathologic subtype. We hypothesize that MUC expression in cyst fluid and serum can identify lesions with high risk of malignancy. Methods: Cyst fluid and serum were collected from 40 patients during pancreatectomy for IPMN between 2005 and 2009. Samples were grouped into low-risk (low-grade or moderate dysplasia, n = 21) and high-risk groups (high-grade dysplasia or carcinoma, n = 19). Mucin expression (MUC1, MUC2, MUC4, and MUC5AC) was assessed utilizing enzyme-linked immunosorbent assays. Results: MUC2 and MUC4 cyst fluid concentrations were elevated in high-risk versus low-risk groups (10 ± 3.0 ng/ml vs. 4.4 ± 1.2 ng/ml, p = 0.03; 20.6 ± 10.6 ng/ml vs. 4.5 ± 1.4 ng/ml, p = 0.03, respectively). Corresponding serum samples revealed higher levels of MUC5AC in high-risk compared with low-risk patients (19.9 ± 9.3 ng/ml vs. 2.2 ± 1.1 ng/ml, p = 0.04). Histopathologic subtype was significantly associated with grade of dysplasia, and the intestinal subtype displayed increased MUC2 cyst fluid concentrations (13.8 ± 6.5 ng/ml vs. 4.1 ± 0.9 ng/ml, p = 0.02). Conclusions: In this study, high-risk IPMN showed elevated cyst fluid concentrations of MUC2 and MUC4, and increased serum levels of MUC5AC. High-risk IPMN also displayed a distinct mucin expression profile in specific histologic subtypes. These data, if validated, may allow surgeons to more appropriately select patients for operative resection. © 2010 Society of Surgical Oncology.
Keywords: clinical article; human tissue; protein expression; histopathology; cancer risk; pancreas resection; protein blood level; tumor volume; intraductal papillary mucinous tumor; pancreas cyst; cyst fluid; enzyme linked immunosorbent assay; prediction; high risk patient; risk assessment; pancreas carcinoma; disease severity; mucin 1; dysplasia; mucin 5ac; mucin 2; mucin 4
Journal Title: Annals of Surgical Oncology
Volume: 18
Issue: 1
ISSN: 1068-9265
Publisher: Springer  
Date Published: 2011-01-01
Start Page: 199
End Page: 206
Language: English
DOI: 10.1245/s10434-010-1225-7
PROVIDER: scopus
PUBMED: 20717734
PMCID: PMC4241376
DOI/URL:
Notes: --- - "Export Date: 4 March 2011" - "CODEN: ASONF" - "Source: Scopus"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Murray F Brennan
    1059 Brennan
  2. Ronald P DeMatteo
    637 DeMatteo
  3. Mithat Gonen
    1028 Gonen
  4. Ajay V Maker
    10 Maker
  5. Nora Katabi
    303 Katabi
  6. Peter Allen
    501 Allen
  7. William R Jarnagin
    903 Jarnagin
  8. Yuman Fong
    775 Fong